
Eli Lilly Takes Legal Action Against Telehealth Companies for Selling Unapproved Drugs
Eli Lilly has filed lawsuits against telehealth companies for selling unapproved drugs containing tirzepatide, risking patient safety. βοΈπ
Discover the newest research about AI innovations in π° News.

Eli Lilly has filed lawsuits against telehealth companies for selling unapproved drugs containing tirzepatide, risking patient safety. βοΈπ

HeartBeam and AccurKardia collaborate to improve cardiac diagnostics with advanced ECG analysis software. πβ€οΈ

New AI tools aim to improve trust and usability in healthcare. π€π Enhanced patient engagement and streamlined processes are key benefits.

Blue Shield of California shared data with Google, affecting 4.7 million members. No sensitive information was disclosed. ππ

Ardent Health’s new CDIO, Anika Gardenhire, focuses on human-centric technology to enhance patient and provider experiences. π₯π»

Samsung Medical Center reduces medical record issuance time to just 5 minutes through automation and AI technology. π₯π
Online registration for GP practices in England has surged, with 98.4% now offering this service. π² Over 3.8 million patients have registered online since November 2022. π₯

AI adoption in healthcare faces challenges like trust, accuracy, training, and intellectual property concerns. Addressing these is crucial. π₯π€

Leidos invests $10 million with the University of Pittsburgh to enhance AI in disease detection and management. π₯π€

Hippocratic AI partners with Burjeel Holdings to enhance healthcare delivery in the MENA region using generative AI. π€π